Immunogenicity and Safety of the Inactivated, Split-Virion Influenza Vaccine, Northern Hemisphere 2008-2009 Formulation

Clinical trial NCT00718146 · COMPLETED

Trial details

NCT number: NCT00718146
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Influenza Orthomyxoviridae Infections

Start date: 2008-06-01
Primary completion: 2008-08-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.